DDInter790 DDInter1224
Furosemide is a potent loop diuretic that acts on the kidneys to ultimately increase water loss from the body. It is an anthranilic acid derivative. Furosemide is used for edema secondary to various clinical conditions, such as congestive heart failure exacerbation, liver failure, renal failure, and high blood pressure. It mainly works by inhibiting electrolyte reabsorption from the kidneys and enhancing the excretion of water from the body. Furosemide has a fast onset and short duration of action and has been used safely and effectively in both pediatric and adult patients. The use of furosemide is particularly beneficial in clinical settings that require a drug with a higher diuretic potential. In addition to oral formulations, the solution for intravenous and intramuscular administration is also available, which is typically limited to patients who are unable to take oral medication or for patients in emergency clinical situations.
Minocycline was first described in the literacture in 1966. It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria. Like other semisynthetic tetracyclines, minocycline has modifications to carbons 7-9 on the D ring to generate higher efficacy than previous tetracyclines. Minocycline was granted FDA approval on 30 June 1971.
Furosemide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Minocycline
Furosemide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Minocycline
Furosemide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Doxycycline
Doxycycline {u} (Compound) resembles {v} (Compound) Minocycline
Furosemide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Doxycycline
Doxycycline {u} (Compound) resembles {v} (Compound) Minocycline
Furosemide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Oxytetracycline
Oxytetracycline {u} (Compound) resembles {v} (Compound) Minocycline
Furosemide {u} (Compound) treats {v} (Disease) hypertension
hypertension {u} (Disease) is associated with {v} (Gene) ALOX5
ALOX5 {u} (Gene) is bound by {v} (Compound) Minocycline
Furosemide {u} (Compound) resembles {v} (Compound) Indapamide
Indapamide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Oxytetracycline
Oxytetracycline {u} (Compound) resembles {v} (Compound) Minocycline
Furosemide {u} (Compound) binds {v} (Gene) ALB
ALB {u} (Gene) is bound by {v} (Compound) Etacrynic acid
Etacrynic acid {u} may cause a minor interaction that can limit clinical effects when taken with {v} Minocycline
Furosemide {u} (Compound) binds {v} (Gene) SLC22A8
SLC22A8 {u} (Gene) is bound by {v} (Compound) Methotrexate
Methotrexate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Minocycline
Furosemide {u} (Compound) palliates {v} (Disease) chronic kidney failure
chronic kidney failure {u} (Disease) is associated with {v} (Gene) VEGFA
VEGFA {u} (Gene) is bound by {v} (Compound) Minocycline
Furosemide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Minocycline (Compound)
Furosemide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Minocycline
Furosemide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Doxycycline (Compound) and Doxycycline (Compound) resembles Minocycline (Compound)
Furosemide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Doxycycline and Doxycycline (Compound) resembles Minocycline (Compound)
Furosemide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Oxytetracycline (Compound) and Oxytetracycline (Compound) resembles Minocycline (Compound)
Furosemide (Compound) treats hypertension (Disease) and hypertension (Disease) is associated with ALOX5 (Gene) and ALOX5 (Gene) is bound by Minocycline (Compound)
Furosemide (Compound) resembles Indapamide (Compound) and Indapamide may cause a minor interaction that can limit clinical effects when taken with Oxytetracycline and Oxytetracycline (Compound) resembles Minocycline (Compound)
Furosemide (Compound) binds ALB (Gene) and ALB (Gene) is bound by Etacrynic acid (Compound) and Etacrynic acid may cause a minor interaction that can limit clinical effects when taken with Minocycline
Furosemide (Compound) binds SLC22A8 (Gene) and SLC22A8 (Gene) is bound by Methotrexate (Compound) and Methotrexate may cause a moderate interaction that could exacerbate diseases when taken with Minocycline
Furosemide (Compound) palliates chronic kidney failure (Disease) and chronic kidney failure (Disease) is associated with VEGFA (Gene) and VEGFA (Gene) is bound by Minocycline (Compound)